Johnson & Johnson’s strong second-quarter earnings are thanks to the company’s focus on long-term goals, particularly in the pharmaceutical business, said CEO Alex Gorsky.
Gorsky joined FBN’s Maria Bartiromo Thursday to discuss the company’s earnings and future plans. Johnson & Johnson (JNJ) sales grew by 9.1% in the second quarter to $19.5 billion, beating expectations of $18.99 billion.
Help employers find you! Check out all the jobs and post your resume.
